The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy. Then it smashed into roadblocks - shortages that led Novo to limit demand by ...

MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

UnitedHealth Group (NYSE:UNH) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high.

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

There are other advantages that collagen holds over GLP-1 drugs. The main advantage, according to Dr Milagro, is that the ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

A recent survey of six medical specialties in 15 U.S. metropolitan areas finds that the average wait time for physician appointments has increased significantly in recent years. Specialties most ...

Keros Therapeutics, a biotech currently engaged in a public fight with one of its largest shareholders over the future ...

Novo Nordisk faces resistance from Connecticut clinic in Ozempic and Wegovy dispute | LIVation admits to referencing Novo ...